# Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population

> clinical trial · VERIFIED · 2026-07-20

Status: RECRUITING · Sponsor: Novartis Pharmaceuticals · Condition: Hidradenitis Suppurativa

- Company: Novartis Pharmaceuticals
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT07543419

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.